524 related articles for article (PubMed ID: 32985336)
1. Bacteriophage endolysins as a potential weapon to combat
Mondal SI; Draper LA; Ross RP; Hill C
Gut Microbes; 2020 Nov; 12(1):1813533. PubMed ID: 32985336
[No Abstract] [Full Text] [Related]
2. Characterization of an Endolysin Targeting
Mondal SI; Akter A; Draper LA; Ross RP; Hill C
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073633
[No Abstract] [Full Text] [Related]
3. A Novel Bacteriophage with Broad Host Range against Clostridioides difficile Ribotype 078 Supports SlpA as the Likely Phage Receptor.
Whittle MJ; Bilverstone TW; van Esveld RJ; Lücke AC; Lister MM; Kuehne SA; Minton NP
Microbiol Spectr; 2022 Feb; 10(1):e0229521. PubMed ID: 35107319
[TBL] [Abstract][Full Text] [Related]
4.
Selle K; Fletcher JR; Tuson H; Schmitt DS; McMillan L; Vridhambal GS; Rivera AJ; Montgomery SA; Fortier LC; Barrangou R; Theriot CM; Ousterout DG
mBio; 2020 Mar; 11(2):. PubMed ID: 32156803
[No Abstract] [Full Text] [Related]
5. Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes.
Lesniak NA; Schubert AM; Sinani H; Schloss PD
mSphere; 2021 May; 6(3):. PubMed ID: 33952668
[TBL] [Abstract][Full Text] [Related]
6. Potential Role of the Host-Derived Cell-Wall Binding Domain of Endolysin CD16/50L as a Molecular Anchor in Preservation of Uninfected Clostridioides difficile for New Rounds of Phage Infection.
Phothichaisri W; Chankhamhaengdecha S; Janvilisri T; Nuadthaisong J; Phetruen T; Fagan RP; Chanarat S
Microbiol Spectr; 2022 Apr; 10(2):e0236121. PubMed ID: 35377223
[TBL] [Abstract][Full Text] [Related]
7. Fidaxomicin for the treatment of
Skinner AM; Scardina T; Kociolek LK
Future Microbiol; 2020 Jul; 15(11):967-979. PubMed ID: 32715754
[TBL] [Abstract][Full Text] [Related]
8. Structure-based modification of a Clostridium difficile-targeting endolysin affects activity and host range.
Mayer MJ; Garefalaki V; Spoerl R; Narbad A; Meijers R
J Bacteriol; 2011 Oct; 193(19):5477-86. PubMed ID: 21803993
[TBL] [Abstract][Full Text] [Related]
9. An Osmotic Laxative Renders Mice Susceptible to Prolonged Clostridioides difficile Colonization and Hinders Clearance.
Tomkovich S; Taylor A; King J; Colovas J; Bishop L; McBride K; Royzenblat S; Lesniak NA; Bergin IL; Schloss PD
mSphere; 2021 Oct; 6(5):e0062921. PubMed ID: 34585964
[TBL] [Abstract][Full Text] [Related]
10. Ridinilazole: a novel therapy for Clostridium difficile infection.
Vickers RJ; Tillotson G; Goldstein EJ; Citron DM; Garey KW; Wilcox MH
Int J Antimicrob Agents; 2016 Aug; 48(2):137-43. PubMed ID: 27283730
[TBL] [Abstract][Full Text] [Related]
11. Advances in the diagnosis and treatment of Clostridium difficile infections.
Peng Z; Ling L; Stratton CW; Li C; Polage CR; Wu B; Tang YW
Emerg Microbes Infect; 2018 Feb; 7(1):15. PubMed ID: 29434201
[TBL] [Abstract][Full Text] [Related]
12. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic?
Hawes AM; Desai A; Patel PK
Anaerobe; 2021 Aug; 70():102384. PubMed ID: 34029702
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of a Clostridium difficile bacteriophage and its cloned biologically active endolysin.
Mayer MJ; Narbad A; Gasson MJ
J Bacteriol; 2008 Oct; 190(20):6734-40. PubMed ID: 18708505
[TBL] [Abstract][Full Text] [Related]
14. Clostridioides difficile phage biology and application.
Heuler J; Fortier LC; Sun X
FEMS Microbiol Rev; 2021 Sep; 45(5):. PubMed ID: 33580957
[TBL] [Abstract][Full Text] [Related]
15. Microbiota-based Therapies Clostridioides difficile infection that is refractory to antibiotic therapy.
Mehta SR; Yen EF
Transl Res; 2021 Apr; 230():197-207. PubMed ID: 33278650
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial resistance in Clostridioides difficile.
O'Grady K; Knight DR; Riley TV
Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2459-2478. PubMed ID: 34427801
[TBL] [Abstract][Full Text] [Related]
17. The (p)ppGpp Synthetase RSH Mediates Stationary-Phase Onset and Antibiotic Stress Survival in Clostridioides difficile.
Pokhrel A; Poudel A; Castro KB; Celestine MJ; Oludiran A; Rinehold AJ; Resek AM; Mhanna MA; Purcell EB
J Bacteriol; 2020 Sep; 202(19):. PubMed ID: 32661079
[TBL] [Abstract][Full Text] [Related]
18. Clostridioides difficile Biofilm.
Vuotto C; Donelli G; Buckley A; Chilton C
Adv Exp Med Biol; 2024; 1435():249-272. PubMed ID: 38175479
[TBL] [Abstract][Full Text] [Related]
19. Microbiota-based markers predictive of development of Clostridioides difficile infection.
Berkell M; Mysara M; Xavier BB; van Werkhoven CH; Monsieurs P; Lammens C; Ducher A; Vehreschild MJGT; Goossens H; de Gunzburg J; Bonten MJM; Malhotra-Kumar S;
Nat Commun; 2021 Apr; 12(1):2241. PubMed ID: 33854066
[TBL] [Abstract][Full Text] [Related]
20. Assessing the Feasibility of Employing a Combination of a Bacteriophage-Derived Endolysin and Spore Germinants to Treat Relapsing
Alyahya K; Baillie L
Microorganisms; 2023 Jun; 11(7):. PubMed ID: 37512824
[No Abstract] [Full Text] [Related]
[Next] [New Search]
